<html><head><title>Last Compo BVF INC/IL</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>BVF INC/IL<br>#assets : 68<br>AUMs(M$) : 2,542</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>name</th>
      <th>mktcap</th>
      <th>sector</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
    <tr>
      <th>ticker</th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>OLMA US</th>
      <td>OLEMA PHARMACEUTICALS INC</td>
      <td>1578.23</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">12.6</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">12.6</div></td>
    </tr>
    <tr>
      <th>XOMA US</th>
      <td>XOMA CORP DEL</td>
      <td>395.87</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">7.2</div></td>
      <td>XOMA CORP DEL</td>
      <td>30September20</td>
      <td>4.2</td>
      <td><div p style="color:black;background:#dbfad2;">3.0</div></td>
    </tr>
    <tr>
      <th>KYMR US</th>
      <td>KYMERA THERAPEUTICS INC</td>
      <td>2318.22</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>6.4</td>
      <td>KYMERA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>4.6</td>
      <td>1.8</td>
    </tr>
    <tr>
      <th>RLAY US</th>
      <td>RELAY THERAPEUTICS INC</td>
      <td>3400.53</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">5.0</div></td>
      <td>RELAY THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>7.8</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.8</div></td>
    </tr>
    <tr>
      <th>RVMD US</th>
      <td>REVOLUTION MEDICINES INC</td>
      <td>2876.50</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>4.3</td>
      <td>REVOLUTION MEDICINES INC</td>
      <td>30September20</td>
      <td>3.9</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>MRUS US</th>
      <td>MERUS N V</td>
      <td>727.88</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>4.0</td>
      <td>MERUS N V</td>
      <td>30September20</td>
      <td>3.6</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>RPTX US</th>
      <td>REPARE THERAPEUTICS INC</td>
      <td>1032.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>4.0</td>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>5.1</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>CYTK US</th>
      <td>CYTOKINETICS INC</td>
      <td>1211.12</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>3.9</td>
      <td>CYTOKINETICS INC</td>
      <td>30September20</td>
      <td>3.9</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>PTGX US</th>
      <td>PROTAGONIST THERAPEUTICS INC</td>
      <td>942.47</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>3.3</td>
      <td>PROTAGONIST THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.5</td>
      <td>0.8</td>
    </tr>
    <tr>
      <th>IONS US</th>
      <td>IONIS PHARMACEUTICALS INC</td>
      <td>6469.81</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>3.0</td>
      <td>IONIS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.8</td>
      <td>1.2</td>
    </tr>
    <tr>
      <th>RCUS US</th>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>1866.36</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>2.8</td>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>XENE US</th>
      <td>XENON PHARMACEUTICALS INC</td>
      <td>425.27</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>2.1</td>
      <td>XENON PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>2.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>XNCR US</th>
      <td>XENCOR INC</td>
      <td>2396.62</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">2.1</div></td>
      <td>XENCOR INC</td>
      <td>30September20</td>
      <td>4.3</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.2</div></td>
    </tr>
    <tr>
      <th>AMRN US</th>
      <td>AMARIN CORP PLC</td>
      <td>2474.47</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>2.0</td>
      <td>AMARIN CORP PLC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>1.8</td>
    </tr>
    <tr>
      <th>ACIU US</th>
      <td>AC IMMUNE SA</td>
      <td>479.89</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.9</td>
      <td>AC IMMUNE SA</td>
      <td>30September20</td>
      <td>2.6</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>35104E100</th>
      <td>4D MOLECULAR THERAPEUTICS IN</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.8</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.8</td>
    </tr>
    <tr>
      <th>00166B105</th>
      <td>ALX ONCOLOGY HLDGS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.8</td>
      <td>ALX ONCOLOGY HLDGS INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>IDYA US</th>
      <td>IDEAYA BIOSCIENCES INC</td>
      <td>370.79</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.7</td>
      <td>IDEAYA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>EPI CN</th>
      <td>ESSA PHARMA INC</td>
      <td>186.11</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.7</td>
      <td>ESSA PHARMA INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>SPRO US</th>
      <td>SPERO THERAPEUTICS INC</td>
      <td>392.90</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.7</td>
      <td>SPERO THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>0.9</td>
    </tr>
    <tr>
      <th>KURA US</th>
      <td>KURA ONCOLOGY INC</td>
      <td>1856.23</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.6</td>
      <td>KURA ONCOLOGY INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>STRO US</th>
      <td>SUTRO BIOPHARMA INC</td>
      <td>721.60</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.5</td>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>CTMX US</th>
      <td>CYTOMX THERAPEUTICS INC</td>
      <td>457.38</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>CYTOMX THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>INFI US</th>
      <td>INFINITY PHARMACEUTICALS INC</td>
      <td>289.06</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>INFINITY PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>528872302</th>
      <td>LEXICON PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.4</td>
    </tr>
    <tr>
      <th>GLYC US</th>
      <td>GLYCOMIMETICS INC</td>
      <td>160.56</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>GLYCOMIMETICS INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>FBRX US</th>
      <td>FORTE BIOSCIENCES INC</td>
      <td>380.93</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>FORTE BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>-1.0</td>
    </tr>
    <tr>
      <th>CALT US</th>
      <td>CALLIDITAS THERAPEUTICS AB</td>
      <td>695.42</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>CALLIDITAS THERAPEUTICS AB</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>IMVT US</th>
      <td>IMMUNOVANT INC</td>
      <td>3926.43</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.9</td>
      <td>IMMUNOVANT INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>-1.3</td>
    </tr>
    <tr>
      <th>VSTM US</th>
      <td>VERASTEM INC</td>
      <td>306.60</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.9</td>
      <td>VERASTEM INC</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>CTIC US</th>
      <td>CTI BIOPHARMA CORP</td>
      <td>209.42</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.8</td>
      <td>CTI BIOPHARMA CORP</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>CALA US</th>
      <td>CALITHERA BIOSCIENCES INC</td>
      <td>189.96</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.8</td>
      <td>CALITHERA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>MTEM US</th>
      <td>MOLECULAR TEMPLATES INC</td>
      <td>571.69</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.7</td>
      <td>MOLECULAR TEMPLATES INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>SNDX US</th>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>816.54</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.7</td>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>-1.2</td>
    </tr>
    <tr>
      <th>ARGX US</th>
      <td>ARGENX SE</td>
      <td>15505.34</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.7</td>
      <td>ARGENX SE</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>-1.7</td>
    </tr>
    <tr>
      <th>FPRX US</th>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>717.83</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>-1.4</td>
    </tr>
    <tr>
      <th>19240Q201</th>
      <td>COGENT BIOSCIENCES INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>88339T103</th>
      <td>THERAPEUTICS ACQUISITION COR</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>THERAPEUTICS ACQUISITION COR</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>PIRS US</th>
      <td>PIERIS PHARMACEUTICALS INC</td>
      <td>136.65</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>PIERIS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>MEIP US</th>
      <td>MEI PHARMA INC</td>
      <td>268.70</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>MEI PHARMA INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>GMDA US</th>
      <td>GAMIDA CELL LTD</td>
      <td>283.74</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>GAMIDA CELL LTD</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>67011N204</th>
      <td>NOVUS THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>OVID US</th>
      <td>OVID THERAPEUTICS INC</td>
      <td>138.43</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>OVID THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>39868T105</th>
      <td>GRITSTONE ONCOLOGY INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>SELB US</th>
      <td><div p style="background:#fcfa72;">SELECTA BIOSCIENCES INC</div></td>
      <td>288.22</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>SELECTA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>CFRX US</th>
      <td>CONTRAFECT CORP</td>
      <td>131.45</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>CONTRAFECT CORP</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>GNCA US</th>
      <td>GENOCEA BIOSCIENCES INC</td>
      <td>91.42</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>GENOCEA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>05492W103</th>
      <td>BCTG ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>BCTG ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>G3710A121</th>
      <td>FRAZIER LIFESCIENCES ACQU CO</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>CRVS US</th>
      <td>CORVUS PHARMACEUTICALS INC</td>
      <td>93.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>CORVUS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>XFOR US</th>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>93.48</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>CDTX US</th>
      <td>CIDARA THERAPEUTICS INC</td>
      <td>85.76</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>CIDARA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>GLMD US</th>
      <td>GALMED PHARMACEUTICALS LTD</td>
      <td>64.32</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>GALMED PHARMACEUTICALS LTD</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>G3141W114</th>
      <td>EUCRATES BIOMEDICAL ACQU COR</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>CRIS US</th>
      <td>CURIS INC</td>
      <td>91.05</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>CURIS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>ERYP US</th>
      <td>ERYTECH PHARMA</td>
      <td>148.92</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>ERYTECH PHARMA</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>33836P105</th>
      <td>5 01 ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>RGLS US</th>
      <td>REGULUS THERAPEUTICS INC</td>
      <td>24.19</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>REGULUS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>867328874</th>
      <td>SUNESIS PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>SUNESIS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>47760M102</th>
      <td>JIYA ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>FWP US</th>
      <td>FORWARD PHARMA A/S</td>
      <td>40.05</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>FORWARD PHARMA A/S</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>PHAT US</th>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>1103.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>30315R107</th>
      <td>F-STAR THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>SWTX US</th>
      <td>SPRINGWORKS THERAPEUTICS INC</td>
      <td>3584.54</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">0.0</div></td>
      <td>SPRINGWORKS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>5.3</td>
      <td><div p style="color:black;background:#f5d2ce;">-5.3</div></td>
    </tr>
    <tr>
      <th>76200L309</th>
      <td>REZOLUTE INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>698102209</th>
      <td>PANACEA ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>PANACEA ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>60463E202</th>
      <td>MIRAGEN THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>53229E103</th>
      <td>LIFESCI ACQUISITION II CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>15117B202</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>CELLDEX THERAPEUTICS INC NEW</td>
      <td>30September20</td>
      <td>2.4</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.4</div></td>
    </tr>
    <tr>
      <th>76029N106</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>REPLIMUNE GROUP INC</td>
      <td>30September20</td>
      <td>2.1</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.1</div></td>
    </tr>
    <tr>
      <th>032724106</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>ANAPTYSBIO INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>299734103</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>EVELO BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>09071M205</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>BIOLINERX LTD</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>67011N105</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>NOVUS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>849431101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>SPRING BK PHARMACEUTICALS IN</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>30161Q104</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>EXELIXIS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.